Suboxone treatment for opioid use disorder
Suboxone (buprenorphine + naloxone) is one of the most widely used and best-evidenced MAT medications for OUD. Covered by Kentucky Medicaid plans typically, with both office-based and integrated treatment options.
Kentucky Medicaid plans typically cover Suboxone
Kentucky Medicaid plans typically cover Suboxone for opioid use disorder. Specific formulations may have different pharmacy prior authorization requirements, but the benefit is universal across plans.
Aetna Better Health
View Aetna Better Health Suboxone coverage →Anthem Medicaid
View Anthem Medicaid Suboxone coverage →Humana Healthy Horizons
View Humana Healthy Horizons Suboxone coverage →Passport
View Passport Suboxone coverage →UnitedHealthcare Community Plan
View UnitedHealthcare Community Plan Suboxone coverage →WellCare
View WellCare Suboxone coverage →The three phases of Suboxone treatment
1. Induction
Suboxone is started after the patient is in moderate withdrawal from their last opioid use. Starting too early can produce precipitated withdrawal — a sharp, sudden worsening of symptoms. Induction is supervised in a clinical setting and dose-titrated based on response.
2. Maintenance
Once a stable dose is found (typically 8–24 mg daily), patients enter the maintenance phase. Most patients remain on a steady maintenance dose for months to years, paired with ongoing therapy and regular clinical check-ins. Maintenance is when MAT delivers the largest mortality and quality-of-life benefits.
3. Taper
Tapering off Suboxone, when clinically appropriate, is gradual — typically over months — and always planned with a prescriber. Many patients choose to remain on Suboxone indefinitely; the clinical evidence supports long-term maintenance.
Suboxone vs. methadone vs. Vivitrol
| Suboxone | Methadone | Vivitrol | |
|---|---|---|---|
| Mechanism | Partial agonist | Full agonist | Antagonist |
| Setting | Office-based | OTP only | Office-based |
| Frequency | Daily oral | Daily on-site | Monthly injection |
| Pre-treatment opioid-free | ~12-24 hrs | None required | 7-14 days |
| Overdose risk profile | Low (ceiling effect) | Moderate | None |
Verify your Suboxone coverage and start treatment
Call us or send a message — we'll discuss your situation and help you understand your treatment options.
Frequently asked questions
Does Kentucky Medicaid cover Suboxone?
Yes. Kentucky Medicaid plans typically cover Suboxone for opioid use disorder. Specific formulations (film vs. tablet, generic vs. brand) may have different prior authorization requirements depending on the Medicaid plan's preferred drug list.
How is Suboxone different from methadone?
Suboxone is a partial opioid agonist with a built-in ceiling effect on respiratory depression — making overdose risk much lower than methadone. Suboxone can be prescribed in office-based settings; methadone for OUD must be dispensed at federally licensed Opioid Treatment Programs (OTPs).
Will Suboxone make me feel high?
No. At therapeutic doses, Suboxone relieves cravings and prevents withdrawal without producing euphoria. The partial agonist mechanism produces a 'ceiling effect' — taking more does not create stronger effects.
How long should I stay on Suboxone?
Suboxone is a long-term treatment for many patients. Research consistently shows that longer MAT correlates with lower overdose mortality. Tapering, when clinically appropriate, should be gradual and planned with your prescriber.